NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
ID: 351679Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351679

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-089.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jan 3, 2024 12:00 AM
  4. 4
    Due Nov 13, 2026 12:00 AM
Description

The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research. This grant opportunity aims to support intensive supervised research training and career development experiences for clinician scientists (Scholars) in the field of substance use and substance use disorder research. The program is designed to help Scholars achieve research independence in this area. The maximum award ceiling for this grant is $750,000. The deadline for applications is November 13, 2026. For more information and to apply, please visit the following link: NIDA Mentored Clinical Scientist Development Program Award. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
PAR-24-089-Full-Announcement.html
4/10/2024
Similar Opportunities
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)". This grant aims to support doctoral candidates from various academic disciplines for up to two years to complete their doctoral dissertation research project. The research projects should align with NIDA funding priorities and the NIDA Strategic Plan. The goal of this award is to enhance the pool of highly talented researchers in the field of substance use/substance use disorder (SU(D)) research. The NIH encourages applications from individuals who can contribute to diversifying the research workforce. The grant does not require cost sharing or matching. The eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-U.S. components of U.S. Organizations are not eligible to apply. The grant opportunity will close on September 7, 2026. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-23-194.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-194.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)". This grant aims to support educational activities that enhance the knowledge of substance use and substance use disorder research. It is intended for individuals in clinically focused careers and/or those training for careers as clinicians/health service providers, clinical researchers, or a combination of both. The grant does not support non-research-related clinical training. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The category of funding activity is health. The grant has been posted and the closing date for applications is November 15, 2024. The maximum award ceiling is $350,000. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-320.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-320.html). If you have any inquiries, please contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) grant. This grant aims to support early career investigators who propose high-impact projects that lead to advances in equity across populations affected by substance use-related harms. The grant is open to applicants from various fields of research, and the research projects should focus on persistent or intractable challenges that drive disparities in medical and other consequences related to substance use and substance use disorder (SUD) across different population groups. The grant does not require cost sharing or matching. The maximum award ceiling is $700,000. The deadline for application submission is November 14, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html).
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)". This grant aims to support early career researchers or clinicians with a background in addiction to develop expertise in implementation science. The grant recipients will receive training in implementation science methods and will be required to propose a research project that applies these methods to at least one of the four priority domains of the HHS Overdose Prevention Strategy: primary prevention, opioid use disorder (OUD) treatment, harm reduction, and/or recovery support services. The ultimate goal of this grant is to build a group of implementation researchers who can contribute to addressing the current overdose crisis, improve the quality of addiction clinical practice, and become the next generation of implementation experts and mentors. The grant has a funding ceiling of $275,000 and does not require cost sharing or matching. The deadline for applications is November 12, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAS-22-206.html](http://grants.nih.gov/grants/guide/pa-files/PAS-22-206.html).
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)". This funding opportunity aims to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by supporting a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have a high impact and quickly yield the necessary results to advance medications closer to FDA approval. The funding will be in the form of short-term (up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This opportunity will enable critical medications development studies that would not be feasible using the traditional R01 activity code. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The grant has a closing date of September 1, 2025, and an award ceiling of $5,000,000. For more information and to apply, visit the following link: [Grant Opportunity Details](https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.